Will DPP-4 inhibitors replace sulfonylureas in the treatment of type 2 diabetes? Contra

被引：0
|
作者：
Mueller, U. A. [1 ]
机构：
[1] Univ Klinikum Jena, Innere Med Klin 3, FB Endokrinol & Stoffwechselerkrankungen, D-07740 Jena, Germany
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2011年 / 136卷 / 11期
关键词：
DPP-4; inhibitor; glucagon-like peptide-1; sulfonylureas; oral antidiabetic drugs; ischemic preconditioning;
D O I：
10.1055/s-0031-1272566
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：547 / 547
页数：1
相关论文
共 50 条
  • [1] Will DPP-4 inhibitors replace sulfonylureas in the treatment of type 2 diabetes? Pro
    Nauck, M. A.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (11) : 546 - 546
  • [2] DPP-4 inhibitors in the treatment of type 2 diabetes
    Duez, Helene
    Cariou, Bertrand
    Staels, Bart
    BIOCHEMICAL PHARMACOLOGY, 2012, 83 (07) : 823 - 832
  • [3] Are Sulfonylureas Less Desirable Than DPP-4 Inhibitors as Add-on to Metformin in the Treatment of Type 2 Diabetes?
    Ahren, Bo
    CURRENT DIABETES REPORTS, 2011, 11 (02) : 83 - 90
  • [4] Are Sulfonylureas Less Desirable Than DPP-4 Inhibitors as Add-on to Metformin in the Treatment of Type 2 Diabetes?
    Bo Ahrén
    Current Diabetes Reports, 2011, 11 : 83 - 90
  • [5] Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetes
    Sutton, Jon M.
    Clark, David E.
    Dunsdon, Stephen J.
    Fenton, Garry
    Fillmore, Amanda
    Harris, Neil V.
    Higgs, Chris
    Hurley, Chris A.
    Krintel, Sussie L.
    MacKenzie, Robert E.
    Duttaroy, Alokesh
    Gangl, Eric
    Maniara, Wiesia
    Sedrani, Richard
    Namoto, Kenji
    Ostermann, Nils
    Gerhartz, Bernd
    Sirockin, Finton
    Trappe, Joerg
    Hassiepen, Ulrich
    Baeschlin, Daniel K.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (03) : 1464 - 1468
  • [6] Sulfonylureas or Dipeptidyl Peptidase (DPP-4) Inhibitors in the Management of Type 2 Diabetes: Debate is Not yet Closed
    Guillausseau, Pierre-Jean
    CURRENT DIABETES REPORTS, 2011, 11 (06) : 461 - 462
  • [7] Sulfonylureas or Dipeptidyl Peptidase (DPP-4) Inhibitors in the Management of Type 2 Diabetes: Debate is Not yet Closed
    Pierre-Jean Guillausseau
    Current Diabetes Reports, 2011, 11 : 461 - 462
  • [8] Need for streamlined use of DPP-4 inhibitors in the treatment of type 2 diabetes
    Cristiana Vitale
    Giuseppe M. C. Rosano
    Krishna Prasad
    Cardiovascular Diabetology, 15
  • [9] Type 2 Diabetes Comorbidities and Treatment Challenges: Rationale for DPP-4 Inhibitors
    Hollander, Priscilla A.
    Kushner, Pamela
    POSTGRADUATE MEDICINE, 2010, 122 (03) : 71 - 80
  • [10] Need for streamlined use of DPP-4 inhibitors in the treatment of type 2 diabetes
    Vitale, Cristiana
    Rosano, Giuseppe M. C.
    Prasad, Krishna
    CARDIOVASCULAR DIABETOLOGY, 2016, 15
12345